<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>How Two Common Medications Became One $455 Million Specialty Pill</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2017/06/21/how-two-common-medications-became-one-455-million-specialty-pill.aspx</link><description>An investigative reporter who wondered why he&amp;rsquo;d been given a drug his doctor didn&amp;rsquo;t mention during his examine has pulled the curtain on drug companies&amp;rsquo; tricks for making old drugs new &amp;mdash; and more expensive. As reported by ProPublica</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>